查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
製藥 4.0 市場，按技術、按應用、按最終用戶、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1351421

製藥 4.0 市場，按技術、按應用、按最終用戶、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Pharma 4.0 Market, By Technology, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年，製藥 4.0 市場規模達 109 億美元，2023 年至 2030 年年複合成長率為 17.7%。

Pharma 4.0 渴望透過利用即時數據驅動的洞察、預測建模和智慧系統互連的力量來簡化流程、提高產品品質並實現敏捷的決策流程。最終，它致力於開創一個以患者為中心的醫療保健時代，提供更多以患者為中心和永續的解決方案。在此過程中，它採用技術創新來有效應對製藥領域不斷變化的挑戰和機會。

製藥 4.0 市場 - 市場動態：

  • 加速藥物開發和推出新療法以推動市場需求的壓力越來越大
  • 製藥業在解決複雜疾病和迅速滿足不斷變化的患者需求方面面臨越來越多的挑戰。 Pharma 4.0 的出現開創了一個新時代，為藥物開發、臨床試驗預測建模和增強的生產流程提供了更有效的途徑。這種轉變取決於人工智慧、機器學習和數據分析等先進技術的整合。
  • 製藥 4.0 不僅可以顯著節省時間和成本，還增強了業界應對突發健康危機、監管變化和消費者需求變化的適應性。因此，它營造了一種加速創新的氛圍，並改善了突破性的救生療法的可及性，為患者開創了醫療保健的新時代。

製藥 4.0 市場 - 主要見解：

  • 根據我們的研究分析師分享的見解，全球製藥 4.0 市場預計將顯著成長，預計 2023 年至 2030 年的預測期內年複合成長率 (CAGR) 約為 18.2%。
  • 該行業的擴張受到重要因素的支撐，最顯著的是加快藥物開發過程並將新療法推向市場的壓力越來越大。
  • 在技​​術細分的背景下，人工智慧成為最突出的類別，佔據了 2022 年的大部分市場佔有率。
  • 此外，在應用細分領域，臨床試驗將在2022年佔據領先地位，凸顯了Pharma 4.0在最佳化和加速臨床研究流程方面的關鍵作用。
  • 從區域角度來看，北美將成為 2022 年的主要收入貢獻者，反映出該地區致力於將 Pharma 4.0 作為推動創新和提高醫療保健成果的手段。

製藥 4.0 市場區隔分析：

  • 全球製藥 4.0 市場呈現多方面的細分結構，包括技術、應用、最終用戶和地理區域作為主要部分。
  • 在技​​術分類的框架下，市場分類了三個不同的類別：雲端運算、人工智慧、巨量資料分析和物聯網。值得注意的是，人工智慧領域佔據了主導地位，成為市場的主導力量。
  • 製藥 4.0 利用人工智慧 (AI) 的能力，開啟製藥業的變革時代。人工智慧驅動的演算法有助於破解複雜的資料集、加快藥物研究、提供對臨床試驗結果的預測性見解以及最佳化生產流程。人工智慧和製藥 4.0 之間的這種共生關係促進了範式轉變，其特點是增強決策、加強創新和採用以患者為中心的方法。最終，這種協同作用將形成一個醫療保健生態系統，不僅生產力更高，而且能夠對不斷變化的醫療保健需求做出高度反應。

製藥4.0市場-競爭格局：

製藥4.0的競爭格局是一個充滿活力的舞台，其特點是老牌製藥巨頭和創新新創企業的融合。儘管輝瑞（Pfizer）、諾華（Novartis）和羅氏（Roche）等行業巨頭投入了大量資源來擁抱數位轉型，但一波在人工智慧、數據分析和自動化方面擁有專業知識的利基企業和技術新創公司正在透過引入顛覆性解決方案而嶄露頭角。

在這種情況下，一個值得注意的趨勢是製藥公司和技術提供者之間的合作精神。他們正在建立夥伴關係和聯盟，培育創新文化。新興的製藥4.0市場的競爭集中在建立強大的數據平台、先進的分析能力和敏捷的製造系統。這些努力旨在透過加速藥物發現、最佳化供應鏈和提供個人化醫療保健解決方案來賦予競爭優勢，以滿足醫療保健生態系統不斷變化的需求。

目錄

第 1 章：製藥 4.0 市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 製藥 4.0 市場片段（依技術）
    • 製藥 4.0 市場片段（依應用）
    • 最終用戶的製藥 4.0 市場片段
    • 按國家/地區分類的製藥 4.0 市場片段
    • 按地區分類的製藥 4.0 市場片段
  • 競爭洞察

第 3 章：製藥 4.0 主要市場趨勢

  • 製藥 4.0 市場促進因素
    • 市場促進因素的影響分析
  • 製藥4.0市場限制
    • 市場限制影響分析
  • 製藥4.0市場機會
  • 製藥4.0市場未來趨勢

第 4 章：製藥 4.0 產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：製藥 4.0 市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長部分
    • 最鬆散的部分
    • 邊際損失部分

第 6 章：製藥 4.0 市場格局

  • 2022 年製藥 4.0 市佔率分析
  • 按主要製造商分類的故障數據
    • 既定玩家分析
    • 新興玩家分析

第 7 章：製藥 4.0 市場 - 按技術

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 雲端運算
    • 人工智慧
    • 巨量資料分析
    • 物聯網

第 8 章：製藥 4.0 市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 藥物發現與開發
    • 臨床試驗
    • 製造業

第 9 章：製藥 4.0 市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 製藥公司
    • 生技公司
    • CRO 和 CMO

第 10 章：製藥 4.0 市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 製藥 4.0 北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 製藥 4.0 歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 製藥4.0亞太地區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按技術）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 製藥 4.0 拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按技術）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 製藥 4.0 中東和非洲主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 製藥 4.0 產業

  • 競爭儀表板
  • 公司簡介
    • Pfizer Inc.
    • Roche Holding AG
    • Novartis AG
    • Johnson & Johnson
    • GlaxoSmithKline plc
    • Sanofi SA
    • AstraZeneca plc
    • Merck & Co., Inc.
    • Eli Lilly and Company
    • AbbVie Inc.
    • Boehringer Ingelheim International GmbH
    • Takeda Pharmaceutical Company Limited
    • Bristol Myers Squibb Company
    • Moderna, Inc.
    • Regeneron Pharmaceuticals, Inc.

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1656

REPORT HIGHLIGHT

Pharma 4.0 Market size was valued at USD 10,900 Million in 2022, expanding at a CAGR of 17.7% from 2023 to 2030.

Pharma 4.0 represents the integration of cutting-edge digital technologies, data analytics, robotics, and artificial intelligence into the pharmaceutical industry, aligning with the principles of the fourth industrial revolution. This transformative concept aims to revolutionize various facets of the pharmaceutical sector, encompassing drug research, development, manufacturing, and patient care. Its overarching goals include bolstering operational efficiency, expediting innovation, optimizing supply chain operations, and facilitating the implementation of personalized medicine.

Pharma 4.0 aspires to streamline processes, elevate product quality, and empower agile decision-making processes by harnessing the power of real-time data-driven insights, predictive modeling, and the interconnectivity of smart systems. Ultimately, it strives to usher in an era of healthcare that revolves around the patient, delivering more patient-centric and sustainable solutions. In doing so, it embraces technological innovations to effectively address the ever-evolving challenges and opportunities within the pharmaceutical landscape.

Pharma 4.0 Market - Market Dynamics:

  • Increasing pressure to accelerate drug development and bring new therapies to propel market demand
  • The pharmaceutical industry grapples with mounting challenges in addressing intricate diseases and meeting evolving patient needs with expediency. The advent of Pharma 4.0 has ushered in a new era, offering more efficient avenues for drug development, predictive modeling for clinical trials, and enhanced production processes. This transformation hinges on the integration of advanced technologies such as artificial intelligence, machine learning, and data analytics.
  • Pharma 4.0 not only delivers notable time and cost savings but also enhances the industry's adaptability in responding to emergent health crises, regulatory shifts, and shifting consumer demands. Consequently, it fosters a climate of accelerated innovation and improved accessibility to groundbreaking, life-saving therapies, ushering in a new era of healthcare for patients.

Pharma 4.0 Market - Key Insights:

  • According to insights shared by our research analyst, the global Pharma 4.0 market is poised for remarkable growth, with a projected Compound Annual Growth Rate (CAGR) of approximately 18.2% during the forecast period spanning from 2023 to 2030.
  • This industry's expansion is underpinned by significant factors, most notably the mounting pressure to expedite drug development processes and introduce novel therapies to market.
  • Within the context of Technology segmentation, Artificial Intelligence emerges as the standout category, capturing the majority of the market share for the year 2022.
  • Furthermore, in the realm of application segmentation, Clinical Trials takes the lead in 2022, underscoring the pivotal role of Pharma 4.0 in optimizing and expediting clinical research processes.
  • From a regional perspective, North America emerges as the primary revenue contributor in the year 2022, reflecting the region's commitment to embracing Pharma 4.0 as a means to drive innovation and enhance healthcare outcomes.

Pharma 4.0 Market- Segmentation Analysis:

  • The Global Pharma 4.0 Market exhibits a multifaceted segmentation structure, comprising Technology, Application, End-User, and Geographical Region as its primary divisions.
  • Under the umbrella of Technology classification, the market delineates three distinct categories: Cloud Computing, Artificial Intelligence, Big Data Analytics, and the Internet of Things. Remarkably, it is the Artificial Intelligence sector that asserts its dominance, emerging as the predominant force within the market.
  • Pharma 4.0 harnesses the capabilities of artificial intelligence (AI) to usher in a transformative era for the pharmaceutical sector. AI-powered algorithms are instrumental in deciphering complex datasets, expediting drug research, offering predictive insights into clinical trial outcomes, and optimizing production processes. This symbiotic relationship between AI and Pharma 4.0 fosters a paradigm shift characterized by enhanced decision-making, heightened innovation, and the adoption of patient-centric approaches. Ultimately, this synergy results in a healthcare ecosystem that is not only more productive but also highly responsive to evolving healthcare needs.

Pharma 4.0 Market- Competitive Landscape:

Pharma 4.0's competitive landscape is a dynamic arena characterized by the convergence of established pharmaceutical giants and innovative startups. While industry stalwarts like Pfizer, Novartis, and Roche commit substantial resources to embrace the digital transformation, a wave of niche players and technology startups with expertise in AI, data analytics, and automation are making their mark by introducing disruptive solutions.

In this landscape, a noteworthy trend is the collaborative spirit between pharmaceutical firms and technology providers. They are forging partnerships and alliances, fostering a culture of innovation. The competition in the burgeoning Pharma 4.0 market is centered on the establishment of robust data platforms, sophisticated analytics capabilities, and agile manufacturing systems. These endeavors aim to confer a competitive edge by accelerating drug discovery, optimizing supply chains, and delivering personalized healthcare solutions to meet the evolving needs of the healthcare ecosystem.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PHARMA 4.0 MARKET KEY PLAYERS

  • Pfizer Inc.
  • Roche Holding AG
  • Novartis AG
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • AstraZeneca plc
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • AbbVie Inc.
  • Boehringer Ingelheim International GmbH
  • Takeda Pharmaceutical Company Limited
  • Bristol Myers Squibb Company
  • Moderna, Inc.
  • Regeneron Pharmaceuticals, Inc.

GLOBAL PHARMA 4.0 MARKET, BY TECHNOLOGY

  • Cloud Computing
  • Artificial Intelligence
  • Big Data Analytics
  • Internet of Things

GLOBAL PHARMA 4.0 MARKET, BY APPLICATION

  • Drug Discovery and Development
  • Clinical Trials
  • Manufacturing

GLOBAL PHARMA 4.0 MARKET, BY END-USER

  • Pharmaceutical Companies
  • Biotechnology Companies
  • CROs and CMOs

GLOBAL PHARMA 4.0 MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Pharma 4.0 Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pharma 4.0 Market Snippet by Technology
    • 2.1.2. Pharma 4.0 Market Snippet by Application
    • 2.1.3. Pharma 4.0 Market Snippet by End-User
    • 2.1.4. Pharma 4.0 Market Snippet by Country
    • 2.1.5. Pharma 4.0 Market Snippet by Region
  • 2.2. Competitive Insights

3. Pharma 4.0 Key Market Trends

  • 3.1. Pharma 4.0 Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pharma 4.0 Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pharma 4.0 Market Opportunities
  • 3.4. Pharma 4.0 Market Future Trends

4. Pharma 4.0 Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pharma 4.0 Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Pharma 4.0 Market Landscape

  • 6.1. Pharma 4.0 Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pharma 4.0 Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
    • 7.1.2. Cloud Computing
    • 7.1.3. Artificial Intelligence
    • 7.1.4. Big Data Analytics
    • 7.1.5. Internet of Things

8. Pharma 4.0 Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Drug Discovery and Development
    • 8.1.3. Clinical Trials
    • 8.1.4. Manufacturing

9. Pharma 4.0 Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Pharmaceutical Companies
    • 9.1.3. Biotechnology Companies
    • 9.1.4. CROs and CMOs

10. Pharma 4.0 Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pharma 4.0 Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pharma 4.0 Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pharma 4.0 Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Pharma 4.0 Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Pharma 4.0 Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Pharma 4.0 Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. Roche Holding AG
    • 11.2.3. Novartis AG
    • 11.2.4. Johnson & Johnson
    • 11.2.5. GlaxoSmithKline plc
    • 11.2.6. Sanofi S.A.
    • 11.2.7. AstraZeneca plc
    • 11.2.8. Merck & Co., Inc.
    • 11.2.9. Eli Lilly and Company
    • 11.2.10. AbbVie Inc.
    • 11.2.11. Boehringer Ingelheim International GmbH
    • 11.2.12. Takeda Pharmaceutical Company Limited
    • 11.2.13. Bristol Myers Squibb Company
    • 11.2.14. Moderna, Inc.
    • 11.2.15. Regeneron Pharmaceuticals, Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Pharma 4.0 Market: Technology Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Pharma 4.0 Market, by Technology 2018-2030 (USD Million)
  • TABLE Pharma 4.0 Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Pharma 4.0 Market, by Application 2018-2030 (USD Million)
  • TABLE Pharma 4.0 Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Pharma 4.0 Market, by End-User 2018-2030 (USD Million)
  • TABLE Pharma 4.0 Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Pharma 4.0 Market, by Region 2018-2030 (USD Million)
  • TABLE North America Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
  • TABLE North America Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
  • TABLE Europe Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
  • TABLE Latin America Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)